Management ChangeJul 27, 2026, 04:03 PM
Kymera Therapeutics Appoints Terence Rooney as Chief Medical Officer
AI Summary
Kymera Therapeutics announced the appointment of Terence Rooney, MD, as its new Chief Medical Officer. Dr. Rooney, formerly an immunology leader at Johnson & Johnson, will lead the company's clinical development strategy for its oral immunology portfolio. He succeeds Jared Gollob, MD, who will retire after eight years but will continue as an advisor through the end of the year.
Key Highlights
- Kymera Therapeutics appointed Terence Rooney, MD, as its new Chief Medical Officer.
- Dr. Rooney will lead the company's global clinical development strategy for its oral immunology portfolio.
- Jared Gollob, MD, will retire from his CMO role after eight years but will remain an advisor through year-end.
- Dr. Rooney previously served as Senior Vice President, Portfolio and Asset Management Leader, Immunology, at Johnson & Johnson.
- His experience includes advancing immunology therapies from early clinical stages through commercialization.
- Dr. Rooney has contributed to successful marketing applications for medicines like ICOTYDE®, IMAAVY®, OLUMIANT®, STELARA®, and TREMFYA®.
Price Impact
More from KYMR